In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.

253Activity of Eravacycline Against Enterobacteriaceae and Acinetobacter baumannii from New York City

253. Activity of Eravacycline Against Enterobacteriaceae and Acinetobacter baumannii from New York City Marie Abdallah, MD; Olawole Olafisoye, MD; Christopher Cortes, MD; Carl Urban, PhD; David Landman, MD; John Quale, MD; Infectious Diseases, SUNY Downstate Medical Center, Brooklyn, NY; Infectious Diseases, New York Hospital Queens, Flushing, NY; Infectious Disease, New York Hospital Queens, F...

261Comparative in vitro Activity of Sitafloxacin and Other Antibiotics Against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii and Carbapenem-Resistant Pseudomonas aeruginosa by Disk Diffusion Method

Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.

CONTEXT Infections caused by carbapenem-resistant bacteria constitute a major challenge for current medical practice. OBJECTIVE To describe treatment and outcome of carbapenem-resistant Gram-negative bacilli (GNB) blood-stream infection (BSI) caused by these organisms at a tertiary care hospital in Mumbai. METHODS Carbapenem-resistant isolates from blood cultures were collected from January...

What remains against carbapenem-resistant Enterobacteriaceae and Acinetobacter spp? Evaluation of Tigecycline and Colistin

Nosocomial infection by multi-drug resistant bacteria (MDR) e.g: extended-spectrumBeta-lactamase(ESBL) producing Enterobacteriaceae, Acinetobacter baumannii and carbapenem-resistant Enterobacteriaceae (CRE) is increased worldwide, with major burden due to limited choices of antibiotics (Peleg & Hooper, 2010, Magiorakos et al.,2012). Tigecycline (TIG) and Colistin (COL) are examples of the few d...

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016

The in vitro activity of the investigational siderophore cephalosporin, cefiderocol (formerly S-649266), was determined against a 2014-2016, 52-country, worldwide collection of clinical isolates of carbapenem-nonsusceptible Enterobacteriaceae (n = 1,022), multidrug-resistant (MDR) Acinetobacter baumannii (n = 368), MDR Pseudomonas aeruginosa (n = 262), Stenotrophomonas maltophilia (n = 217), an...